High Content Screening Market, By Product (Instruments (Cell Imaging Analysis Systems, and Flow Cytometers), Consumables (Reagent and Assay Kits, Micro Plates, and Other Consumables), Software, Services, and Accessories), By Application (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling, and Other Applications), By End-User (Pharmaceutical and Biotechnology Companies, Academic and Government Institute, and Contract Research Organization), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030

Report Code: PMI391320 | Publish Date: April 2024 | No. of Pages: 180

Global High Content Screening Market Overview

Introduction:

High-content screening (HCS) is a method that is used in biological research and drug discovery to identify substances, such as small molecules, peptides, or RNAi that alter the phenotype of a cell in a desired manner. High-content screening includes any method used to analyze whole cells or components of cells with a simultaneous readout of several parameters. High-content screening can be employed to analyze whole cells or certain components of cells with simultaneous data collection of numerous factors.

Global High Content Screening Market Dynamics

The major factors that are expected to be driving the high content screening market are need for cost containment in pharma R&D, growth in funding for cellular research, and technological advancements. The high cost and long duration of drug development are compelling pharmaceutical companies to revise their R&D expenditure. The conventional method of toxicity studies involves the screening of large libraries in search of potential drug candidates. This method is expensive, resource- & time-consuming, and has a low success rate. Hence, high content screening solutions for testing the potential toxicity of chemicals and complex substances are being adopted by pharmaceutical companies to improve in vitro toxicity testing by reducing the time and cost. This is fueling the growth of the high-content screening market and is expected to act as a major driver for this market during the forecast period. On the other hand, the high cost of instruments and the dearth of knowledgeable and skilled personnel for the operation of high-content screening instruments are expected to restrain the global market growth to a certain extent. Pharmaceutical companies require many such systems and hence their capital costs increase significantly. Moreover, the maintenance costs and several other indirect expenses increase the total cost of ownership of these instruments. High cost, therefore, hinders the wide adoption of high content screening instruments in both clinical and research applications, especially in emerging nations.  As High content screening instruments are expensive, they add to the overall drug development expense for pharmaceutical and biopharmaceutical companies.  Budgetary restrictions among academic institutes restrict the purchase of these instruments. Also, the handling of these equipment requires skilled professionals. As a result, many companies and academic institutes prefer to outsource high content screening services to CROs. Due to the rising demand for outsourced service providers, an increasing number of CROs are offering high content screening services. This, in turn, serves as an opportunity for the growth of the target market.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Global High Content Screening Market Segmentation

High content screening market is segmented based on product, application, end-user, and region.

Based on product, the high content screening market is segmented into the instruments, consumables, software, services, and accessories. The instrument is further segmented into cell imaging analysis systems, and flow cytometers. In addition, the consumables is further classified into reagent and assay kits, micro plates, and other consumables. Based on the application, the target market is segmented into primary and secondary screening, target identification and validation, toxicity studies, compound profiling, and other applications. Based on end-users, the target market is bifurcated into pharmaceutical and biotechnology companies, academic and government institute, and contract research organization.

Regional Insights:

Based on the region the high content screening market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America held the largest share of the high content screening market owing to significant growth factors including increasing incidences of chronic diseases, rising prevalence of geriatric population, various collaborations with research institutes, and high disposable income and advanced healthcare infrastructure. It is followed by Europe which owing to factors such as high healthcare investments and government regulations in the region. Asia Pacific is anticipated to be the fastest growing market over the forecast period as a consequence of prominent factors such as rising disposable income, increasing need of novel drugs, and increasing patient awareness about the technologies integrated with improving healthcare infrastructure.

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

High Content Screening Market, By Product:

  •  Instruments
    • Cell Imaging Analysis Systems
    • Flow Cytometers
  • Consumables
    • Reagent and Assay Kits
    • Micro Plates
    • Other Consumables
  • Software
  •  Services
  • Accessories

High Content Screening Market, By Application:

  • Primary and Secondary Screening
  • Target Identification and Validation
  • Toxicity Studies, Compound Profiling
  • Other Applications

High Content Screening Market, By End-User:

  • Pharmaceutical and Biotechnology Companies
  • Academic and Government Institute
  • Contract Research Organization

High Content Screening Market, By Region:

  • North America
    • Middle East & Africa
      • Middle East & Africa High Content Screening Market, By Product
      • Middle East & Africa High Content Screening Market, By Application
      • Middle East & Africa High Content Screening Market, By End-User
      • Middle East & Africa High Content Screening Market, By Country
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East & Africa
    • Latin America
      • Latin America High Content Screening Market, By Product
      • Latin America High Content Screening Market, By Application
      • Latin America High Content Screening Market, By End-User
      • Latin America High Content Screening Market, By Country
        • Brazil
        • Mexico
        • Rest of Latin America
    • Asia Pacific
      • Asia Pacific High Content Screening Market, By Product
      • Asia Pacific High Content Screening Market, By Application
      • Asia Pacific High Content Screening Market, By End-User
      • Asia Pacific High Content Screening Market, By Country
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Europe
      • Europe High Content Screening Market, By Product
      • Europe High Content Screening Market, By Application
      • Europe High Content Screening Market, By End-User
      • Europe High Content Screening Market, By Country
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • North America High Content Screening Market, By Product
    • North America High Content Screening Market, By Application
    • North America High Content Screening Market, By End-User
    • North America High Content Screening Market, By Country
      •  U.S.
      • Canada

Global High Content Screening Market Key Players

 

                                                                                   

The key players operating the high content screening market are GE Healthcare, Danaher Corporation, Thermo Fisher Scientific, Perkinelmer Inc., Tecan Group , Biotek Instruments Inc., Becton, Dickinson And Company, Bio-Rad Laboratories, Yokogawa Electric Corporation, and   Ncardia.  For Instance, In February 2019, Ncardia announced the launch of their discovery hit drug screening platform which will help the researcher to access human diseases early in the drug discovery process. The aim is to provide better medicines to the patients.

Global High Content Screening Market Company Profile

  • GE Healthcare
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
  • Danaher Corporation
  • Thermo Fisher Scientific
  • Perkinelmer, Inc.
  • Tecan Group
  • Biotek Instruments Inc.
  • Becton, Dickinson And Company
  • Bio-Rad Laboratories
  • Yokogawa Electric Corporation
  • Ncardia

 “*” marked represents similar segmentation in other categories in the respective section.

Global High Content Screening Market Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Industry Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Purview
    • Executive Summary
    • Key Findings—Global Outlook for High Content Screening Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Product
      • Market Snippet, By Application
      • Market Snippet, By End-User
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Market Segmentation, By Product, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Instruments
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
        • Cell Imaging Analysis Systems
        • Flow Cytometers
    • Consumables
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
        • Reagent and Assay Kits
        • Micro Plates
        • Other Consumables
    •  Software
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Services
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    •  Accessories
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  6. Market Segmentation, By Application, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Primary and Secondary Screening
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Target Identification and Validation
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Toxicity Studies
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Compound Profiling
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Other Applications
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  7. Market Segmentation, By End-User, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Pharmaceutical and Biotechnology Companies
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Academic and Government Institute
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Contract Research Organization
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  8. Global Market, By Region, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  9. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  10. Company Profiles
      • GE Healthcare
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Danaher Corporation
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Thermo Fisher Scientific
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Perkinelmer, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Tecan Group
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Biotek Instrument Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Becton, Dickinson and Company
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Bio-Rad Laboratories
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Yokagawa Electric Corporation
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Ncardia
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
  11. The Last Word
    • Future Impact
    • About Us
    • Contact

FAQs

High Content Screening Market report segments the market basis of product, application, end-user, and region.

The major factors that are expected to be driving the high content screening market are need for cost containment in pharma R&D, growth in funding for cellular research, and technological advancements.

North America held the largest share of the high content screening market

The key players operating the high content screening market are GE Healthcare, Danaher Corporation, Thermo Fisher Scientific, Perkinelmer Inc., Tecan Group , Biotek Instruments Inc., Becton, Dickinson And Company, Bio-Rad Laboratories, Yokogawa Electric Corporation, and Ncardia.